Scientists look inside the brain to see how MS drug works
NCT ID NCT05974852
Summary
This study looked back at brain scans from a previous clinical trial to see if the multiple sclerosis drug ocrelizumab causes changes in a specific brain area called the choroid plexus. Researchers analyzed MRI scans from 732 people with primary progressive MS who had participated in the earlier trial. The goal was to gather knowledge about how the drug might work in the brain, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Buffalo Neuroimaging Analysis Center
Buffalo, New York, 14203, United States
Conditions
Explore the condition pages connected to this study.